 | • レポートコード：GIR-107A12063 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗老化療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗老化療法の種類別市場規模（遺伝子治療、免疫療法、その他）、用途別市場規模（心血管疾患、神経変性疾患、眼科疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗老化療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Unity Biotechnology、Siwa Therapeutics、Calico LLC、AgeX Therapeutics，Inc、Numeric Biotech、Human Longevity, Inc. (HLI)、Cleara Biotech、OisinBiotechnologies、Recursion Pharmaceuticals、Sierra Sciences、Proteostasis Therapeutics、Senolytic Therapeutics、Allergan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：遺伝子治療、免疫療法、その他 ・用途別分析2016年-2026年：心血管疾患、神経変性疾患、眼科疾患、その他 ・抗老化療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗老化療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗老化療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗老化療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗老化療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-Senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anti-Senescence Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Anti-Senescence Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Anti-Senescence Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gene Therapy
Immunotherapy
Others
Market segment by Application, can be divided into
Cardiovascular Diseases
Neural Degenerative Diseases
Ophthalmology Disorders
Others
Market segment by players, this report covers
Unity Biotechnology
Siwa Therapeutics
Calico LLC
AgeX Therapeutics，Inc
Numeric Biotech
Human Longevity, Inc. (HLI)
Cleara Biotech
OisinBiotechnologies
Recursion Pharmaceuticals
Sierra Sciences
Proteostasis Therapeutics
Senolytic Therapeutics
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Anti-Senescence Therapy
1.2 Classification of Anti-Senescence Therapy by Type
1.2.1 Overview: Global Anti-Senescence Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Anti-Senescence Therapy Revenue Market Share by Type in 2020
1.2.3 Gene Therapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Global Anti-Senescence Therapy Market by Application
1.3.1 Overview: Global Anti-Senescence Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cardiovascular Diseases
1.3.3 Neural Degenerative Diseases
1.3.4 Ophthalmology Disorders
1.3.5 Others
1.4 Global Anti-Senescence Therapy Market Size & Forecast
1.5 Global Anti-Senescence Therapy Market Size and Forecast by Region
1.5.1 Global Anti-Senescence Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Anti-Senescence Therapy Market Size by Region, (2016-2021)
1.5.3 North America Anti-Senescence Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Anti-Senescence Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Anti-Senescence Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Anti-Senescence Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Anti-Senescence Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Senescence Therapy Market Drivers
1.6.2 Anti-Senescence Therapy Market Restraints
1.6.3 Anti-Senescence Therapy Trends Analysis
2 Company Profiles
2.1 Unity Biotechnology
2.1.1 Unity Biotechnology Details
2.1.2 Unity Biotechnology Major Business
2.1.3 Unity Biotechnology Anti-Senescence Therapy Product and Solutions
2.1.4 Unity Biotechnology Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Unity Biotechnology Recent Developments and Future Plans
2.2 Siwa Therapeutics
2.2.1 Siwa Therapeutics Details
2.2.2 Siwa Therapeutics Major Business
2.2.3 Siwa Therapeutics Anti-Senescence Therapy Product and Solutions
2.2.4 Siwa Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siwa Therapeutics Recent Developments and Future Plans
2.3 Calico LLC
2.3.1 Calico LLC Details
2.3.2 Calico LLC Major Business
2.3.3 Calico LLC Anti-Senescence Therapy Product and Solutions
2.3.4 Calico LLC Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Calico LLC Recent Developments and Future Plans
2.4 AgeX Therapeutics，Inc
2.4.1 AgeX Therapeutics，Inc Details
2.4.2 AgeX Therapeutics，Inc Major Business
2.4.3 AgeX Therapeutics，Inc Anti-Senescence Therapy Product and Solutions
2.4.4 AgeX Therapeutics，Inc Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AgeX Therapeutics，Inc Recent Developments and Future Plans
2.5 Numeric Biotech
2.5.1 Numeric Biotech Details
2.5.2 Numeric Biotech Major Business
2.5.3 Numeric Biotech Anti-Senescence Therapy Product and Solutions
2.5.4 Numeric Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Numeric Biotech Recent Developments and Future Plans
2.6 Human Longevity, Inc. (HLI)
2.6.1 Human Longevity, Inc. (HLI) Details
2.6.2 Human Longevity, Inc. (HLI) Major Business
2.6.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Product and Solutions
2.6.4 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Human Longevity, Inc. (HLI) Recent Developments and Future Plans
2.7 Cleara Biotech
2.7.1 Cleara Biotech Details
2.7.2 Cleara Biotech Major Business
2.7.3 Cleara Biotech Anti-Senescence Therapy Product and Solutions
2.7.4 Cleara Biotech Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cleara Biotech Recent Developments and Future Plans
2.8 OisinBiotechnologies
2.8.1 OisinBiotechnologies Details
2.8.2 OisinBiotechnologies Major Business
2.8.3 OisinBiotechnologies Anti-Senescence Therapy Product and Solutions
2.8.4 OisinBiotechnologies Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 OisinBiotechnologies Recent Developments and Future Plans
2.9 Recursion Pharmaceuticals
2.9.1 Recursion Pharmaceuticals Details
2.9.2 Recursion Pharmaceuticals Major Business
2.9.3 Recursion Pharmaceuticals Anti-Senescence Therapy Product and Solutions
2.9.4 Recursion Pharmaceuticals Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Recursion Pharmaceuticals Recent Developments and Future Plans
2.10 Sierra Sciences
2.10.1 Sierra Sciences Details
2.10.2 Sierra Sciences Major Business
2.10.3 Sierra Sciences Anti-Senescence Therapy Product and Solutions
2.10.4 Sierra Sciences Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sierra Sciences Recent Developments and Future Plans
2.11 Proteostasis Therapeutics
2.11.1 Proteostasis Therapeutics Details
2.11.2 Proteostasis Therapeutics Major Business
2.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Product and Solutions
2.11.4 Proteostasis Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Proteostasis Therapeutics Recent Developments and Future Plans
2.12 Senolytic Therapeutics
2.12.1 Senolytic Therapeutics Details
2.12.2 Senolytic Therapeutics Major Business
2.12.3 Senolytic Therapeutics Anti-Senescence Therapy Product and Solutions
2.12.4 Senolytic Therapeutics Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Senolytic Therapeutics Recent Developments and Future Plans
2.13 Allergan
2.13.1 Allergan Details
2.13.2 Allergan Major Business
2.13.3 Allergan Anti-Senescence Therapy Product and Solutions
2.13.4 Allergan Anti-Senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Allergan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anti-Senescence Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Anti-Senescence Therapy Players Market Share
3.2.2 Top 10 Anti-Senescence Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Anti-Senescence Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Anti-Senescence Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Anti-Senescence Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Anti-Senescence Therapy Revenue Market Share by Application (2016-2021)
5.2 Anti-Senescence Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Anti-Senescence Therapy Revenue by Type (2016-2026)
6.2 North America Anti-Senescence Therapy Revenue by Application (2016-2026)
6.3 North America Anti-Senescence Therapy Market Size by Country
6.3.1 North America Anti-Senescence Therapy Revenue by Country (2016-2026)
6.3.2 United States Anti-Senescence Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Anti-Senescence Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Anti-Senescence Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Anti-Senescence Therapy Revenue by Type (2016-2026)
7.2 Europe Anti-Senescence Therapy Revenue by Application (2016-2026)
7.3 Europe Anti-Senescence Therapy Market Size by Country
7.3.1 Europe Anti-Senescence Therapy Revenue by Country (2016-2026)
7.3.2 Germany Anti-Senescence Therapy Market Size and Forecast (2016-2026)
7.3.3 France Anti-Senescence Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Anti-Senescence Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Anti-Senescence Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Anti-Senescence Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Anti-Senescence Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Anti-Senescence Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Anti-Senescence Therapy Market Size by Region
8.3.1 Asia-Pacific Anti-Senescence Therapy Revenue by Region (2016-2026)
8.3.2 China Anti-Senescence Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Anti-Senescence Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Anti-Senescence Therapy Market Size and Forecast (2016-2026)
8.3.5 India Anti-Senescence Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Anti-Senescence Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Anti-Senescence Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Anti-Senescence Therapy Revenue by Type (2016-2026)
9.2 South America Anti-Senescence Therapy Revenue by Application (2016-2026)
9.3 South America Anti-Senescence Therapy Market Size by Country
9.3.1 South America Anti-Senescence Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Anti-Senescence Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Anti-Senescence Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Anti-Senescence Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Anti-Senescence Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Anti-Senescence Therapy Market Size by Country
10.3.1 Middle East & Africa Anti-Senescence Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Anti-Senescence Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Anti-Senescence Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Anti-Senescence Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Anti-Senescence Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Anti-Senescence Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Anti-Senescence Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Anti-Senescence Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Anti-Senescence Therapy Revenue Market Share by Region (2021-2026)
Table 6. Unity Biotechnology Corporate Information, Head Office, and Major Competitors
Table 7. Unity Biotechnology Major Business
Table 8. Unity Biotechnology Anti-Senescence Therapy Product and Solutions
Table 9. Unity Biotechnology Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siwa Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Siwa Therapeutics Major Business
Table 12. Siwa Therapeutics Anti-Senescence Therapy Product and Solutions
Table 13. Siwa Therapeutics Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Calico LLC Corporate Information, Head Office, and Major Competitors
Table 15. Calico LLC Major Business
Table 16. Calico LLC Anti-Senescence Therapy Product and Solutions
Table 17. Calico LLC Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AgeX Therapeutics，Inc Corporate Information, Head Office, and Major Competitors
Table 19. AgeX Therapeutics，Inc Major Business
Table 20. AgeX Therapeutics，Inc Anti-Senescence Therapy Product and Solutions
Table 21. AgeX Therapeutics，Inc Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Numeric Biotech Corporate Information, Head Office, and Major Competitors
Table 23. Numeric Biotech Major Business
Table 24. Numeric Biotech Anti-Senescence Therapy Product and Solutions
Table 25. Numeric Biotech Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Human Longevity, Inc. (HLI) Corporate Information, Head Office, and Major Competitors
Table 27. Human Longevity, Inc. (HLI) Major Business
Table 28. Human Longevity, Inc. (HLI) Anti-Senescence Therapy Product and Solutions
Table 29. Human Longevity, Inc. (HLI) Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cleara Biotech Corporate Information, Head Office, and Major Competitors
Table 31. Cleara Biotech Major Business
Table 32. Cleara Biotech Anti-Senescence Therapy Product and Solutions
Table 33. Cleara Biotech Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. OisinBiotechnologies Corporate Information, Head Office, and Major Competitors
Table 35. OisinBiotechnologies Major Business
Table 36. OisinBiotechnologies Anti-Senescence Therapy Product and Solutions
Table 37. OisinBiotechnologies Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Recursion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Recursion Pharmaceuticals Major Business
Table 40. Recursion Pharmaceuticals Anti-Senescence Therapy Product and Solutions
Table 41. Recursion Pharmaceuticals Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sierra Sciences Corporate Information, Head Office, and Major Competitors
Table 43. Sierra Sciences Major Business
Table 44. Sierra Sciences Anti-Senescence Therapy Product and Solutions
Table 45. Sierra Sciences Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Proteostasis Therapeutics Corporate Information, Head Office, and Major Competitors
Table 47. Proteostasis Therapeutics Major Business
Table 48. Proteostasis Therapeutics Anti-Senescence Therapy Product and Solutions
Table 49. Proteostasis Therapeutics Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Senolytic Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Senolytic Therapeutics Major Business
Table 52. Senolytic Therapeutics Anti-Senescence Therapy Product and Solutions
Table 53. Senolytic Therapeutics Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Allergan Corporate Information, Head Office, and Major Competitors
Table 55. Allergan Major Business
Table 56. Allergan Anti-Senescence Therapy Product and Solutions
Table 57. Allergan Anti-Senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Anti-Senescence Therapy Revenue (USD Million) by Players (2019-2021)
Table 59. Global Anti-Senescence Therapy Revenue Share by Players (2019-2021)
Table 60. Breakdown of Anti-Senescence Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Anti-Senescence Therapy Players Head Office, Products and Services Provided
Table 62. Anti-Senescence Therapy Mergers & Acquisitions in the Past Five Years
Table 63. Anti-Senescence Therapy New Entrants and Expansion Plans
Table 64. Global Anti-Senescence Therapy Revenue (USD Million) by Type (2016-2021)
Table 65. Global Anti-Senescence Therapy Revenue Share by Type (2016-2021)
Table 66. Global Anti-Senescence Therapy Revenue Forecast by Type (2021-2026)
Table 67. Global Anti-Senescence Therapy Revenue by Application (2016-2021)
Table 68. Global Anti-Senescence Therapy Revenue Forecast by Application (2021-2026)
Table 69. North America Anti-Senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Anti-Senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Anti-Senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Anti-Senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Anti-Senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Anti-Senescence Therapy Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Anti-Senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Anti-Senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Anti-Senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Anti-Senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Anti-Senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Anti-Senescence Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Anti-Senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Anti-Senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Anti-Senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Anti-Senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Anti-Senescence Therapy Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Anti-Senescence Therapy Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Anti-Senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Anti-Senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Anti-Senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Anti-Senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Anti-Senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Anti-Senescence Therapy Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Anti-Senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Anti-Senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Anti-Senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Anti-Senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Anti-Senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Anti-Senescence Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Anti-Senescence Therapy Picture
Figure 2. Global Anti-Senescence Therapy Revenue Market Share by Type in 2020
Figure 3. Gene Therapy
Figure 4. Immunotherapy
Figure 5. Others
Figure 6. Anti-Senescence Therapy Revenue Market Share by Application in 2020
Figure 7. Cardiovascular Diseases Picture
Figure 8. Neural Degenerative Diseases Picture
Figure 9. Ophthalmology Disorders Picture
Figure 10. Others Picture
Figure 11. Global Anti-Senescence Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Anti-Senescence Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Anti-Senescence Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global Anti-Senescence Therapy Revenue Market Share by Region in 2020
Figure 15. North America Anti-Senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Anti-Senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Anti-Senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Anti-Senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Anti-Senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Anti-Senescence Therapy Market Drivers
Figure 21. Anti-Senescence Therapy Market Restraints
Figure 22. Anti-Senescence Therapy Market Trends
Figure 23. Unity Biotechnology Recent Developments and Future Plans
Figure 24. Siwa Therapeutics Recent Developments and Future Plans
Figure 25. Calico LLC Recent Developments and Future Plans
Figure 26. AgeX Therapeutics，Inc Recent Developments and Future Plans
Figure 27. Numeric Biotech Recent Developments and Future Plans
Figure 28. Human Longevity, Inc. (HLI) Recent Developments and Future Plans
Figure 29. Cleara Biotech Recent Developments and Future Plans
Figure 30. OisinBiotechnologies Recent Developments and Future Plans
Figure 31. Recursion Pharmaceuticals Recent Developments and Future Plans
Figure 32. Sierra Sciences Recent Developments and Future Plans
Figure 33. Proteostasis Therapeutics Recent Developments and Future Plans
Figure 34. Senolytic Therapeutics Recent Developments and Future Plans
Figure 35. Allergan Recent Developments and Future Plans
Figure 36. Global Anti-Senescence Therapy Revenue Share by Players in 2020
Figure 37. Anti-Senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Anti-Senescence Therapy Revenue Market Share in 2020
Figure 39. Global Top 10 Players Anti-Senescence Therapy Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Anti-Senescence Therapy Revenue Share by Type in 2020
Figure 42. Global Anti-Senescence Therapy Market Share Forecast by Type (2021-2026)
Figure 43. Global Anti-Senescence Therapy Revenue Share by Application in 2020
Figure 44. Global Anti-Senescence Therapy Market Share Forecast by Application (2021-2026)
Figure 45. North America Anti-Senescence Therapy Sales Market Share by Type (2016-2026)
Figure 46. North America Anti-Senescence Therapy Sales Market Share by Application (2016-2026)
Figure 47. North America Anti-Senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 48. United States Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Anti-Senescence Therapy Sales Market Share by Type (2016-2026)
Figure 52. Europe Anti-Senescence Therapy Sales Market Share by Application (2016-2026)
Figure 53. Europe Anti-Senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 54. Germany Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Anti-Senescence Therapy Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Anti-Senescence Therapy Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Anti-Senescence Therapy Revenue Market Share by Region (2016-2026)
Figure 62. China Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Anti-Senescence Therapy Sales Market Share by Type (2016-2026)
Figure 69. South America Anti-Senescence Therapy Sales Market Share by Application (2016-2026)
Figure 70. South America Anti-Senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Anti-Senescence Therapy Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Anti-Senescence Therapy Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Anti-Senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Anti-Senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の長寿・老化防止療法市場 2021：企業別、地域別、種類・用途別 The Longevity and Anti-senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 長寿及び抗老化療法の世界市場 2019年版：種類別（溶血性薬物療法、遺伝子療法、免疫療法、その他の幹細胞療法）、用途別（病院、医療機関、医薬品＆デバイス販売） Scope of the Report: The global Longevity and Anti-senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- 老化防止療法の世界市場 2019年版：種類別（遺伝子治療、免疫療法、その他）、用途別（心血管疾患、神経変性疾患、眼科疾患、その他） Scope of the Report: The global Anti-Senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
- 世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の陽子線治療市場 2021：企業別、地域別、種類・用途別 The Proton Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…